NCT04604158 Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients Status COMPLETED Phase NA
NCT04593277 Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Cancer Survivors, INSPIRE-AYA Study Status COMPLETED Phase NA
NCT04571138 A Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD22 for Relapsed/Refractory Leukemia or Lymphoma Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT04570423 A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy Status RECRUITING Phase PHASE2
NCT04556266 A Phase I Trial of Donor- Derived 19-28z CAR T Cells Following Allogeneic Transplant for the Treatment of CD19 Malignancies Status WITHDRAWN Phase PHASE1
NCT04541212 Identification and Evaluation of Patients at Risk of Developing Cardiotoxicity After Receiving Chemotherapy for Breast Cancer, Lymphoma or Leukemia Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04514029 Neurotoxicity Prophylaxis With Intrathecal Dexamethasone and Simvastatin Post Axi-Cel Status ACTIVE_NOT_RECRUITING Phase EARLY_PHASE1
NCT04511351 Radiotherapy Combined With GDP With or Without Chidamide in Stage I/II Extranodal Nasal NK/T-cell Lymphoma Status UNKNOWN Phase NA
NCT04504526 Value of Chemokine Receptor CXCR4 Imaging for Diagnosis and Prognostic Evaluation in Lymphoproliferative Diseases Status UNKNOWN Phase EARLY_PHASE1
NCT04497701 Evaluate the Efficacy and Safety of the Prophylactic Use of PEG-rhG-CSF in Children With Hematological Malignancies Status UNKNOWN Phase NA
NCT04496011 Effect of the Cycloergometer in Patients Undergoing Hematopoietic Stem Cell Transplantation Status UNKNOWN Phase NA
NCT04478318 Comparison of Imaging Characteristics of uEXPLORER and Conventional PET/CT in Patients With Lung Cancer, Lymphoma, and Melanoma Status ACTIVE_NOT_RECRUITING Phase NA
NCT04472286 Healthy Bones, Healthy Life: Habitual Physical Activity on Bone & Metabolic Health in Pediatric Cancer Survivors Status COMPLETED Phase N/A
NCT04465760 Xisomab 3G3 for the Prevention of Catheter-Associated Thrombosis in Patients With Cancer Receiving Chemotherapy Status TERMINATED Phase PHASE2
NCT04464798 A Dose Finding and Safety Study of CC-220, Alone and in Combination With an Anti-CD20 Monoclonal Antibody (mAb) in Subjects With Relapsed or Refractory Lymphomas Status TERMINATED Phase PHASE1
NCT04460508 Mecapegfilgrastim(PEG-G-CSF) for Prophylaxis of Chemotherapy-induced Neutropenia in Patients With Lymphoma Status UNKNOWN Phase PHASE2